Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.48 USD | -1.65% | +0.86% | -14.96% |
May. 07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
May. 01 | TD Cowen Adjusts Price Target on Incyte to $80 From $88 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.96% | 12.21B | |
-2.35% | 89.33B | |
+4.08% | 41.19B | |
-14.73% | 31.87B | |
+53.68% | 24.52B | |
-14.48% | 15.68B | |
-8.63% | 12.34B | |
-40.39% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Incyte's Q2 Adjusted Earnings Decline, Revenue Rises; Chief Scientific Officer Dashyant Dhanak to Depart